← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2005Last known activity
Aug 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06555315OfficialN/AAug 1, 2024
- NCT06555315Lead sponsorN/AAug 1, 2024
- NCT04869579Lead sponsorPhase 2Aug 15, 2021
- NCT04869579Overall official - principal investigatorPhase 2Aug 15, 2021
- NCT04869579Reponsible party - principal investigatorPhase 2Aug 15, 2021
- NCT06310642OfficialPhase 4May 20, 2021
- NCT06310642Lead sponsorPhase 4May 20, 2021
- NCT06310642Sponsor investigatorPhase 4May 20, 2021
- NCT00331188Overall official - principal investigatorPhase 3May 1, 2006
- NCT00260234Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2005
- NCT00260234CollaboratorPhase 1/Phase 2Nov 1, 2005
Details
- Last known activity
- Aug 1, 2024